115 related articles for article (PubMed ID: 11872042)
1. Cisplatin-induced in vivo differentiation of human embryonal carcinoma.
Mizutani Y; Sato N; Kawauchi A; Nonomura N; Fukushima M; Miki T
BJU Int; 2002 Mar; 89(4):454-8. PubMed ID: 11872042
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
Miki T; Sawada M; Nonomura N; Kojima Y; Okuyama A; Maeda O; Saiki S; Kotake T
Eur Urol; 1997; 31(1):92-6. PubMed ID: 9032542
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of recombinant human tumor necrosis factor on human testicular tumors heterotransplanted in nude mice.
Miki T; Ishiguro S; Sawada M; Kotake T
Eur Urol; 1994; 25(3):242-7. PubMed ID: 8200408
[TBL] [Abstract][Full Text] [Related]
4. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
5. αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study.
Aide N; Briand M; Bohn P; Dutoit S; Lasnon C; Chasle J; Rouvet J; Modzelewski R; Vela A; Deslandes E; Vera P; Poulain L; Carreiras F
Eur J Nucl Med Mol Imaging; 2011 Feb; 38(2):323-33. PubMed ID: 20882281
[TBL] [Abstract][Full Text] [Related]
6. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
[TBL] [Abstract][Full Text] [Related]
7. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
[TBL] [Abstract][Full Text] [Related]
8. [Bilateral and synchronous testicular teratoma: a case report and literature review].
Matabuena-Tamez P; Canepa-Fernández P; Valencia-García LC; Gutiérrez-Samperio C; Gallegos-Corona MA
Cir Cir; 2015; 83(6):527-31. PubMed ID: 26164135
[TBL] [Abstract][Full Text] [Related]
9. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C
J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922
[TBL] [Abstract][Full Text] [Related]
10. Comparative antitumour activity of cisplatin and two new cisplatin-analogues JM8 and JM9 in human testicular carcinoma xenografts.
Harstrick A; Casper J; Schmoll HJ
Int J Androl; 1987 Feb; 10(1):139-45. PubMed ID: 3034790
[TBL] [Abstract][Full Text] [Related]
11. [Experimental chemotherapy of human testicular carcinoma transplanted in nude mice].
Yanagisawa M; Machida T; Miki M; Tanino M; Akasaka Y; Higashi Y; Kondo N
Gan To Kagaku Ryoho; 1983 May; 10(5):1299-307. PubMed ID: 6191680
[TBL] [Abstract][Full Text] [Related]
12. [Advantages in combination chemotherapy using the camptothecin analogue CPT-11 and cisplatinum analogues for human testicular cancer xenografts].
Miki T; Kotake T
Hinyokika Kiyo; 1993 Dec; 39(12):1221-5. PubMed ID: 8285173
[TBL] [Abstract][Full Text] [Related]
13. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
Drianno N; Robert M; Legouffe E; Guiter J; Navratil H
Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322
[TBL] [Abstract][Full Text] [Related]
14. Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease.
Aide N; Poulain L; Briand M; Dutoit S; Allouche S; Labiche A; Ngo-Van Do A; Nataf V; Batalla A; Gauduchon P; Talbot JN; Montravers F
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):396-405. PubMed ID: 19050878
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours.
Bauer S; Mühlenberg T; Leahy M; Hoiczyk M; Gauler T; Schuler M; Looijenga L
Eur Urol; 2010 Apr; 57(4):679-87. PubMed ID: 19560254
[TBL] [Abstract][Full Text] [Related]
17. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.
Chevreau C; Mazerolles C; Soulié M; Gaspard MH; Mourey L; Bujan L; Plante P; Rischmann P; Bachaud JM; Malavaud B
Eur Urol; 2004 Aug; 46(2):209-14; discussion 214-5. PubMed ID: 15245815
[TBL] [Abstract][Full Text] [Related]
19. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours.
Steiner H; Müller T; Gozzi C; Akkad T; Bartsch G; Berger AP
BJU Int; 2006 Aug; 98(2):349-52. PubMed ID: 16626306
[TBL] [Abstract][Full Text] [Related]
20. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
Schlappack OK; Bush C; Delic JI; Steel GG
Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
